| Line item | 2026-02-28 FY | 2025-02-28 FY | 2024-02-29 FY | 2023-02-28 FY | 2022-02-28 FY | 2021-02-28 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $196.93K | $203.73K | $199.43K | $231.50K | $231.53K | $232.88K |
| R&D | – | – | – | – | – | – |
| SG&A | $196.93K | $203.73K | $199.43K | $231.50K | $231.53K | $232.88K |
| Operating Income | -$196.93K | -$203.73K | -$199.43K | -$231.50K | -$231.53K | -$232.88K |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | -$196.93K | -$203.73K | -$185.38K | -$231.50K | -$231.53K | -$232.88K |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | – | – | – |
| Shares (diluted) | $119.95M | $119.95M | $119.95M | – | – | – |